<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/AEC15D5A-BFD5-4D34-978F-500C126C4FDC"><gtr:id>AEC15D5A-BFD5-4D34-978F-500C126C4FDC</gtr:id><gtr:name>University of Central Lancashire</gtr:name><gtr:department>Sch of Pharmacy and Biomedical Sci</gtr:department><gtr:address><gtr:line4>Preston</gtr:line4><gtr:line5>Lancashire</gtr:line5><gtr:postCode>PR1 2HE</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/AEC15D5A-BFD5-4D34-978F-500C126C4FDC"><gtr:id>AEC15D5A-BFD5-4D34-978F-500C126C4FDC</gtr:id><gtr:name>University of Central Lancashire</gtr:name><gtr:address><gtr:line4>Preston</gtr:line4><gtr:line5>Lancashire</gtr:line5><gtr:postCode>PR1 2HE</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/F54A9E82-C63B-4EDA-BAAC-DD22CFE3D318"><gtr:id>F54A9E82-C63B-4EDA-BAAC-DD22CFE3D318</gtr:id><gtr:firstName>Mary</gtr:firstName><gtr:otherNames>Kathryn</gtr:otherNames><gtr:surname>Phillips-Jones</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=BB%2FM013081%2F1"><gtr:id>CA61FBD0-CB37-4ED5-AA02-A4E6BD09DAB5</gtr:id><gtr:title>Detection of bacterial respiratory infections</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/M013081/1</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2015-05-02</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2014-11-03</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>15548</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Nottingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Biosciences Nottingham</gtr:department><gtr:description>Collaboration with National Centre for Macromolecular Hydrodynamics</gtr:description><gtr:id>3600E229-7802-4A8D-9473-B40E360DF985</gtr:id><gtr:impact>Hussain, R., Hughes, C.S., Ma, P., Harding, S.E., Patching, S.G., Edara, S., Siligardi, G., Henderson, P.J.F. &amp;amp; Phillips-Jones, M.K. Purification of bacterial membrane sensor kinases and biophysical methods for determination of their ligand and inhibitor interactions. Biochem. Soc. Trans. (accepted).</gtr:impact><gtr:partnerContribution>Provision of analytical ultracentrifugation facilities</gtr:partnerContribution><gtr:piContribution>Provision of intact membrane sensor kinases</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>28000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Innovation Fund</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>University of Central Lancashire</gtr:fundingOrg><gtr:id>44E4B836-A317-4D1A-9A66-A07991DF4C63</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-03-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>The research has resulted in a patent GB1517300.8 (filed 30/09/2015). Links have been established with the University's Innovation Office who have found links with engineers who can progress the development of a device to detect bacterial infections. Further circular dichroism experiments to study ligand interactions are planned at the University of Greenwich facility .</gtr:description><gtr:firstYearOfImpact>2015</gtr:firstYearOfImpact><gtr:id>29E70774-39A0-459F-888F-D093BFC2A1FC</gtr:id><gtr:impactTypes><gtr:impactType>Societal,Economic</gtr:impactType></gtr:impactTypes><gtr:sector>Electronics</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Use of knowledge gained from the grant funding to detect bacterial infections</gtr:description><gtr:id>9F657D72-1AC7-4D15-9D2A-3A85A5A1262B</gtr:id><gtr:impact>None aware of</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:patentId>GB1406161.8 and GB1517300.8</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Detection of bacterial infections</gtr:title><gtr:yearProtectionGranted>2014</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:keyFindingsOutput><gtr:description>The main aim of this 6 month grant was to determine the feasibility of expressing certain proteins in an active form to potentially/ultimately develop a device that can detect and distinguish bacterial infections. Many of these proteins are membrane proteins and technically challenging to work with; it is by no means certain that they may be successfully expressed. The aims of this grant therefore were to determine:
(i) whether pheromone-sensing receptors from Streptococcus pneumoniae, Haemophilus influenza and Moraxella catarrhalis and group A streptococci can be successfully expressed in E. coli. Specific objectives were (a) to clone blpH, comD genes from S. pneumoniae, qseC and rbsB of H. influenzae and rbsB from M. catarrhalis and silB of group A streptococci into pTTQ18His, a membrane protein expression plasmid vector that we have previously employed with great success; (b) conduct expression trials using a range of E. coli expression hosts, growth conditions, inducer concentrations and incubation conditions; and (c) time permitted, to conduct larger scale growth expression trials to obtain yield data.
(ii) If expression of at least one receptor is demonstrated above, to pursue further funding to prepare an independent market report to determine demand and scope of the envisaged commercialiised diagnostic test kit.
(iii) Following objective (i) above (ie the scope of the current Pathfinder grant) to begin chimera reporter- and CD-based approaches to develop the diagnostic methodology.

The results of the research established that:
Aim &amp;amp; Objective (i): three proteins (QseC, ComD and BlpH) were successfully expressed (with further proteins also showing promise). These three proteins occur in the main two causative agents of respiratory infections; therefore a sufficient range of proteins were shown to be successfully produced to take the research further. Objectives (a)-(c) were fully accomplished for these three proteins: all three proteins have been optimised with regard to expression, verified as His-tagged proteins and successfully purified from large scale cultures. Aim &amp;amp; Objective (ii): (preparation for further funding) resulted in a successful bid for an Innovation Grant from the University of Central Lancashire which allowed completion of Objective (iii): to continue the project beyond the 6 months of this grant. Therefore all the objectives of the grant were met for three key receptor proteins. Since the grant finished, and using the follow-on Innovation Funding, two receptors have now been used in circular dichroism experiments with the University of Greenwich to show that they are structurally intact after the harsh detergent treatments used to extract them. This confirmation that secondary structure is intact is promising for pheromone interaction experiments which are now underway.</gtr:description><gtr:exploitationPathways>Using Innovation funding from the University of Central Lancashire, the research is being expanded to developing these proteins further for ultimate development of a diagnostic test for distinguishing bacterial from viral respiratory infections and for identifying which bacterial species may be present in bacterial respiratory infection. A patent on the methodology has been filed. Several approaches are being trialled for developing a CD- or reporter-based device involving these purified bacterial receptors that were successfully expressed and purified using this BBSRC Pathfinder funding.</gtr:exploitationPathways><gtr:id>BCDFB997-BBCE-46B5-83C0-EEC5FE1850EF</gtr:id><gtr:sectors><gtr:sector>Agriculture, Food and Drink,Electronics,Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs><gtr:productOutput><gtr:description>Diagnostic test for detecting bacterial infections. Under scientific feasibility development. Funded by an Innovation Grant from the University of Central Lancashire</gtr:description><gtr:id>7172E546-D46F-4AEC-9E70-E29D9F1BCF78</gtr:id><gtr:impact>none known</gtr:impact><gtr:stage>Initial development</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Diagnostic test for detecting bacterial infections</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:yearDevCompleted>2014</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Use of benchtop circular dichroism spectroscopy to investigate ligand binding and structural integrity</gtr:description><gtr:id>5F1D3373-B478-436E-A1A2-847327A0EE87</gtr:id><gtr:impact>None yet</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Use of benchtop circular dichroism spectroscopy to investigate ligand binding and structural integrity</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Application of analytical ultracentrifugation methods (sedimentation velocity and sedimentation equilibrium) to study intact membrane histidine kinases including their ligand interactions and oligomerisation state and molecular mass.</gtr:description><gtr:id>891CFFD3-1533-4F48-9563-347DEF387832</gtr:id><gtr:impact>Publication in Scientific Reports (in press)</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Analytical Ultracentrifugation applied to Membrane Proteins</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">BB/M013081/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>